159 related articles for article (PubMed ID: 25716519)
1. The cascade of care for Australians living with chronic hepatitis B: measuring access to diagnosis, management and treatment.
Allard NL; MacLachlan JH; Cowie BC
Aust N Z J Public Health; 2015 Jun; 39(3):255-9. PubMed ID: 25716519
[TBL] [Abstract][Full Text] [Related]
2. The burden of chronic hepatitis B virus infection in Australia, 2011.
MacLachlan JH; Allard N; Towell V; Cowie BC
Aust N Z J Public Health; 2013 Oct; 37(5):416-22. PubMed ID: 24090323
[TBL] [Abstract][Full Text] [Related]
3. Challenges to the effective delivery of health care to people with chronic hepatitis B in Australia.
Wallace J; McNally S; Richmond J; Hajarizadeh B; Pitts M
Sex Health; 2012 May; 9(2):131-7. PubMed ID: 22498156
[TBL] [Abstract][Full Text] [Related]
4. Mapping progress in chronic hepatitis B: geographic variation in prevalence, diagnosis, monitoring and treatment, 2013-15.
MacLachlan J; Allard N; Carville K; Haynes K; Cowie B
Aust N Z J Public Health; 2018 Feb; 42(1):62-68. PubMed ID: 28712127
[TBL] [Abstract][Full Text] [Related]
5. A "one stop liver shop" approach improves the cascade-of-care for Aboriginal and Torres Strait Islander Australians living with chronic hepatitis B in the Northern Territory of Australia: results of a novel care delivery model.
Hla TK; Bukulatjpi SM; Binks P; Gurruwiwi GG; Dhurrkay RG; Davies J
Int J Equity Health; 2020 May; 19(1):64. PubMed ID: 32381081
[TBL] [Abstract][Full Text] [Related]
6. Cost of treating chronic hepatitis B: comparison of current treatment guidelines.
Robotin M; Patton Y; Kansil M; Penman A; George J
World J Gastroenterol; 2012 Nov; 18(42):6106-13. PubMed ID: 23155339
[TBL] [Abstract][Full Text] [Related]
7. Cultural and linguistic diversity of people living with chronic hepatitis B in 2011-2016: changing migration, shifting epidemiology.
MacLachlan JH; Cowie BC
Aust N Z J Public Health; 2018 Oct; 42(5):441-443. PubMed ID: 30198602
[TBL] [Abstract][Full Text] [Related]
8. Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation.
Robotin MC; Kansil MQ; George J; Howard K; Tipper S; Levy M; Phung N; Penman AG
BMC Health Serv Res; 2010 Jul; 10():215. PubMed ID: 20663140
[TBL] [Abstract][Full Text] [Related]
9. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
[TBL] [Abstract][Full Text] [Related]
10. Modeling Progress Toward Elimination of Hepatitis B in Australia.
McCulloch K; Romero N; MacLachlan J; Allard N; Cowie B
Hepatology; 2020 Apr; 71(4):1170-1181. PubMed ID: 31419332
[TBL] [Abstract][Full Text] [Related]
11. Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.
Toy M; Salomon JA; Jiang H; Gui H; Wang H; Wang J; Richardus JH; Xie Q
Hepatology; 2014 Jul; 60(1):46-55. PubMed ID: 24990105
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.
Bell SJ; Lau A; Thompson A; Watson KJ; Demediuk B; Shaw G; Chen RY; Ayres A; Yuen L; Bartholomeusz A; Locarnini SA; Desmond PV
J Clin Virol; 2005 Feb; 32(2):122-7. PubMed ID: 15653414
[TBL] [Abstract][Full Text] [Related]
13. A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update.
Martin P; Lau DT; Nguyen MH; Janssen HL; Dieterich DT; Peters MG; Jacobson IM
Clin Gastroenterol Hepatol; 2015 Nov; 13(12):2071-87.e16. PubMed ID: 26188135
[TBL] [Abstract][Full Text] [Related]
14. Evidence for the insufficient evaluation and undertreatment of chronic hepatitis B infection in a predominantly low-income and immigrant population.
Jung CW; Tan J; Tan N; Kuo MN; Ashok A; Eells SJ; Miller LG
J Gastroenterol Hepatol; 2010 Feb; 25(2):369-75. PubMed ID: 19929923
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis Rates of Chronic Hepatitis B in Privately Insured Patients in the United States.
Ogawa E; Yeo YH; Dang N; Le MH; Jeong D; Tran S; Henry L; Cheung R; Nguyen MH
JAMA Netw Open; 2020 Apr; 3(4):e201844. PubMed ID: 32271388
[TBL] [Abstract][Full Text] [Related]
16. Promoting hospital and primary care collaboration for timely and effective care for chronic hepatitis B in western Melbourne.
Sievert K; Liddle R; Tan A; Arachchi N; Valaydon Z; Allard N
Aust Health Rev; 2020 Aug; 44(4):521-526. PubMed ID: 32718420
[TBL] [Abstract][Full Text] [Related]
17. The hepatitis B care cascade using administrative claims data, 2016.
Harris AM; Osinubi A; Nelson NP; Thompson WW
Am J Manag Care; 2020 Aug; 26(8):331-338. PubMed ID: 32835460
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.
Fung J; Lai CL; Yuen MF
Expert Rev Anti Infect Ther; 2010 Jun; 8(6):717-26. PubMed ID: 20521898
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B status in migrants and refugees: increasing health burden in Western Australia.
Subramaniam K; Flexman J; Tarquinio L; Thambiran A; Hopkins S; Cheng W
Intern Med J; 2012 Aug; 42(8):880-6. PubMed ID: 22212294
[TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of screening immigrants for hepatitis B.
Wong WW; Woo G; Jenny Heathcote E; Krahn M
Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
